Project ARTISAN: Fostering Aspiration and Resilience Through Intergenerational Storytelling and Arts-based Narratives
Launched by NANYANG TECHNOLOGICAL UNIVERSITY · Jul 10, 2018
Trial Information
Current as of June 04, 2025
Unknown status
Keywords
ClinConnect Summary
Research Objectives
In order to foster and cultivate aspiration and promote resilience in Singapore, stories of life and strength should be discovered and embraced. Through the reflective and expressive strength of arts, this proposed pilot study - Project ARTISAN: fostering Aspiration \& Resilience Through Intergenerational Storytelling \& Art-based Narratives - aspires to empower both seniors and youths through intergenerational storytelling and art making to achieve the following objectives:
1. Empowerment: This research will develop and evaluate a novel, cultural-specific ARTISAN inte...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Youths: Aged 18 to 35
- • Seniors: Aged 60 and above
- • No mobility issues
- • Able to provide informed consent (or assent)
- • Not suffering from major mental health problems
- Exclusion Criteria:
- • Unable to provide consent
- • Suffering from major mental health problems
About Nanyang Technological University
Nanyang Technological University (NTU) is a leading research-intensive institution located in Singapore, renowned for its commitment to advancing knowledge and innovation across various fields, including healthcare and biomedical sciences. As a clinical trial sponsor, NTU leverages its cutting-edge research capabilities and interdisciplinary expertise to facilitate groundbreaking clinical studies aimed at improving patient outcomes and enhancing medical practices. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to ensure rigorous scientific methodologies and ethical standards are upheld throughout the research process. NTU's focus on translating research findings into real-world applications positions it at the forefront of medical advancements and contributes significantly to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Andy HY Ho
Principal Investigator
Nanyang Techological University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials